Both in Pharmaceuticals
Evommune vs Keros Therapeutics
Over the past year EVMN returned −70.6% and KROS returned −33.0%; their daily moves had a correlation of 0.19.
EVMN −70.6% KROS −33.0%Growth of $1, one year, split-adjusted
| Metric | EVMN | KROS |
|---|---|---|
| Price | $5.94 | $10.83 |
| Market cap | $215.6M | $214.7M |
| Today | −1.16% | +0.65% |
| 1 month | −10.7% | −6.0% |
| 6 months | −75.4% | −8.0% |
| Year to date | −65.3% | −46.8% |
| 1 year | — | −28.8% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 14.3× |
| Net cash | $200.4M | $257.6M |
| Dividend yield | — | — |
| Volatility (60d) | 87.1% | 43.2% |
| Short % of float | 15.4% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).